Institution
Bial
Company•Porto, Portugal•
About: Bial is a company organization based out in Porto, Portugal. It is known for research contribution in the topics: Eslicarbazepine acetate & Catechol-O-methyl transferase. The organization has 321 authors who have published 591 publications receiving 30583 citations.
Topics: Eslicarbazepine acetate, Catechol-O-methyl transferase, Tolerability, Population, Pharmacokinetics
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Midro AT, Stengel‐Rutkowski S, Stene J. Experiences with risk estimates for carriers of chromosomal reciprocal translocations.
Abstract: The risk estimates for individual carriers of ten different familial reciprocal translocations detected among 500 couples with reproductive failures are presented. These were established by application of the empirical data analysed by Stengel-Rutkowski et al. (1988) and the guidelines given in Stene & Stengel-Rutkowski (1988). Different risks were estimated for unbalanced offspring at birth or at second trimester prenatal diagnosis for abortions, or stillbirths/early deaths. These risk estimates varied considerably from translocation to translocation. Carriers of five translocations had risks for offspring with single-segment imbalances. The birth risk figures ranged from 0.1% to 13.8%. Carriers of five other translocations had risks for double-segment imbalances with birth risks ranging from 0% to 3.2%. The estimated risk figures were independent of the method of ascertainment. Among the parents of the index cases we found nine maternal carriers and only one paternal carrier. This presentation illustrates the need for individual risk counselling of each carrier with reciprocal translocation regarding further family planning.
58 citations
••
Bial1
TL;DR: This study resulted in the identification of a potent, peripherally selective DBH inhibitor, (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-2-thione hydrochloride 54 (BIA 5-453), which failed to affect NA tissue levels in the brain.
Abstract: A novel series of dopamine beta-hydroxylase (DBH) inhibitors was designed and synthesized incorporating modifications to the core structure of nepicastat 3, with the principal aim of discovering potent DBH inhibitors exerting minimal effects on dopamine (DA) and noradrenaline (NA) levels in the central nervous system. This study resulted in the identification of a potent, peripherally selective DBH inhibitor, (R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-2-thione hydrochloride 54 (BIA 5-453). In experiments in mice and rats at T(max) (9 h after administration), 54 reduced NA levels in a dose-dependent manner in both the left atrium and the left ventricle, with the maximal inhibitory effect attained at a dose of 100 mg/kg. In contrast to that found in the heart, 54 failed to affect NA tissue levels in the brain. Compound 54 is thus presented as a candidate for clinical evaluation for the treatment of chronic heart failure and hypertension.
58 citations
••
Bial1
TL;DR: DHEA, a potent inhibitor of G6P dehydrogenase, inhibited a stimulatory effect of P5C on collagen synthesis, expression of type I collagen and prolidase activity, and the results postulate a potential mechanism of glutamine-induced collagen biosynthesis through its intermediate-P5C.
Abstract: Although glutamine (Gln) is known as an important stimulator of collagen biosynthesis in collagen-producing cells, the mechanism and endpoints by which it regulate the process remain largely unknown. Intermediates of Gln interconversion: glutamate (Glu) and pyrroline-5-carboxylate (P5C) stimulate collagen biosynthesis in cultured cells but evoke different maxima of collagen biosynthesis stimulating activity at different times of incubation. P5C was found to be the most potent stimulator of collagen biosynthesis after 6 h of incubation (approx. three-fold increase); after 12 h, it induced increase in collagen biosynthesis to 260%, while at 24 h, the process was decreased to approximately 80% of control values. Glu induced increase in collagen biosynthesis to approximately 180%, 400% and 120% of control values, after 6, 12 and 24 h, respectively, suggesting that after 12 h of incubation, Glu was the most potent stimulator of collagen biosynthesis. Glu was also the most potent stimulator of type I procollagen expression at this time. After 6, 12 and 24 h incubation, Gln induced collagen biosynthesis to approximately 112, 115 and 230% of control values, respectively. Since prolidase is known to be involved in collagen metabolism, the enzyme activity assay was performed in fibroblasts cultured in the presence of Gln, Glu and P5C. While Gln and Glu required 24 h for maximal stimulation of prolidase activity, P5C induced it after 6–12 h. The data suggest that P5C induced collagen biosynthesis and prolidase activity in a shorter time than Gln and Glu. We considered that P5C directly stimulates the processes, while Gln acts through its intermediate-P5C. Reduction of P5C to proline is coupled to the conversion of glucose-6-phosphate (G6P) to 6-phospho-gluconate, catalyzed by G6P dehydrogenase. We have found that dehydroepiandrosterone (DHEA), a potent inhibitor of G6P dehydrogenase, inhibited a stimulatory effect of P5C on collagen synthesis, expression of type I collagen and prolidase activity. Our results postulate a potential mechanism of glutamine-induced collagen biosynthesis through its intermediate — P5C. P5C-dependent activation of nucleotide biosynthesis, prolidase activity and P5C conversion into proline may contribute to the stimulation of collagen biosynthesis.
58 citations
••
TL;DR: The results indicate that BIA 2-093 and BIA2-024 have sodium channel-blocking properties, but CBZ and OXC are more potent than the new AEDs.
56 citations
••
Bial1
TL;DR: It is concluded that the carbonyl group and preferably unsubstituted aromatic ring are essential features to maintain prolonged peripheral COMT inhibition.
Abstract: A homologous series of novel nitro-catechol structures (7a−7e) were synthesized and tested as inhibitors of the enzyme catechol-O-methyltransferase (COMT). Increasing chain length was found to have significant impact on both brain penetration and duration of COMT inhibition in the rat. Of this series, compound 7b (1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone) was found to exhibit the most potent and selective inhibition of peripheral COMT, with an inhibition profile more similar to entacapone 2 than tolcapone 1 (an equipotent peripheral and central inhibitor) but with much improved duration of action (7b, 70% inhibition and 2, 25% inhibition at 9 h after administration). The effects of structural modifications to 7b on COMT inhibitory profile were investigated, and it is concluded that the carbonyl group and preferably unsubstituted aromatic ring are essential features to maintain prolonged peripheral COMT inhibition. The introduction of the α-methylene group, the major structural difference between ...
56 citations
Authors
Showing all 322 results
Name | H-index | Papers | Citations |
---|---|---|---|
Piotr Jaranowski | 99 | 344 | 64760 |
Peter T. Lansbury | 83 | 203 | 39882 |
Rodrigo A. Cunha | 78 | 317 | 19135 |
Patrício Soares-da-Silva | 55 | 500 | 12239 |
Luís Pereira de Almeida | 50 | 172 | 7108 |
Sławomir J. Grabowski | 48 | 143 | 8606 |
Amílcar Falcão | 42 | 247 | 6994 |
Alberto Martínez | 35 | 103 | 2962 |
Pedro Gomes | 33 | 173 | 3982 |
Teresa G. Nunes | 33 | 127 | 3490 |
Antoine Deschildre | 33 | 234 | 3976 |
Luis Almeida | 33 | 379 | 4854 |
Rui Pinto | 30 | 191 | 3427 |
Juan A. Asturias | 30 | 80 | 2375 |
Paul Moser | 29 | 72 | 3192 |